Literature DB >> 8019557

Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.

M Gessler1, A König, K Arden, P Grundy, S Orkin, S Sallan, C Peters, S Ruyle, J Mandell, F Li.   

Abstract

Homozygous deletions in Wilms' tumor DNA have been a key step in the identification and isolation of the WT1 gene. Several additional loci are also postulated to contribute to Wilms' tumor formation. To assess the frequency of WT1 alterations we have analyzed the WT1 locus in a panel of 77 Wilms' tumors. Eight tumors showed evidence for large deletions of several hundred or thousand kilobasepairs of DNA, some of which were also cytogenetically detected. Additional intragenic mutations were detected using more sensitive SSCP analyses to scan all 10 WT1 exons. Most of these result in premature stop codons or missense mutations that inactivate the remaining WT1 allele. The overall frequency of WT1 alterations detected with these methods is less than 15%. While some mutations may not be detectable with the methods employed, our results suggest that direct alterations of the WT1 gene are present in only a small fraction of Wilms' tumors. Thus, mutations at other Wilms' tumor loci or disturbance of interactions between these genes likely play an important role in Wilms' tumor development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019557     DOI: 10.1002/humu.1380030307

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

Review 1.  Frasier and Denys-Drash syndromes: different disorders or part of a spectrum?

Authors:  A Koziell; R Grundy
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 2.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

3.  WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.

Authors:  Elizabeth J Perlman; Paul E Grundy; James R Anderson; Lawrence J Jennings; Daniel M Green; Jeffrey S Dome; Robert C Shamberger; E Cristy Ruteshouser; Vicki Huff
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

4.  Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.

Authors:  Anja Lehnhardt; Claartje Karnatz; Thurid Ahlenstiel-Grunow; Kerstin Benz; Marcus R Benz; Klemens Budde; Anja K Büscher; Thomas Fehr; Markus Feldkötter; Norbert Graf; Britta Höcker; Therese Jungraithmayr; Günter Klaus; Birgit Koehler; Martin Konrad; Birgitta Kranz; Carmen R Montoya; Dominik Müller; Thomas J Neuhaus; Jun Oh; Lars Pape; Martin Pohl; Brigitte Royer-Pokora; Uwe Querfeld; Reinhard Schneppenheim; Hagen Staude; Giuseppina Spartà; Kirsten Timmermann; Frauke Wilkening; Simone Wygoda; Carsten Bergmann; Markus J Kemper
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-27       Impact factor: 8.237

5.  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.

Authors:  V Schumacher; S Schneider; A Figge; G Wildhardt; D Harms; D Schmidt; A Weirich; R Ludwig; B Royer-Pokora
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

6.  Software and database for the analysis of mutations in the human WT1 gene.

Authors:  C Jeanpierre; C Béroud; P Niaudet; C Junien
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

7.  Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomas.

Authors:  David Ehrlich; Elisabeth Bruder; Martin A Thome; Carsten N Gutt; Magnus von Knebel Doeberitz; Felix Niggli; Alan O Perantoni; Robert Koesters
Journal:  Pediatr Dev Pathol       Date:  2010 Jan-Feb

8.  WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences.

Authors:  V Huff; N Jaffe; G F Saunders; L C Strong; F Villalba; E C Ruteshouser
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

9.  A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5.

Authors:  C Besnard-Guérin; I Newsham; R Winqvist; W K Cavenee
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

10.  The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity.

Authors:  Miguel N Rivera; Woo Jae Kim; Julie Wells; Amanda Stone; Alexa Burger; Erik J Coffman; Jianmin Zhang; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.